Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women’s Health Initiative (WHI) limited-access data set
Open Access
- 1 October 2011
- journal article
- research article
- Published by Elsevier BV in The American Journal of Clinical Nutrition
- Vol. 94 (4), 1144-1149
- https://doi.org/10.3945/ajcn.111.015032
Abstract
Background: Frequent use of personal, nonprotocol calcium supplements obscured an adverse effect of coadministered calcium and vitamin D (CaD) on cardiovascular risk in the Women’s Health Initiative (WHI). Objective: We investigated the effects of the use of personal calcium or vitamin D supplements on other outcomes in the WHI CaD Study (WHI CaD) by using the WHI limited-access clinical trials data set. Design: The WHI CaD was a 7-y, randomized, placebo-controlled trial of CaD (1 g Ca/400 IU vitamin D daily) in 36,282 community-dwelling, postmenopausal women. The incidence of total cancer (excluding nonmelanoma skin cancers), breast and colorectal cancers, hip and total fracture, and mortality was assessed by using Cox proportional hazards models. Results: In the WHI CaD, interactions between the use of either personal calcium or vitamin D supplements and CaD were found for total, breast, and colorectal cancers but not for fracture or mortality. In 15,646 women (43%) who were not taking personal calcium or vitamin D supplements at randomization, CaD significantly decreased the risk of total, breast, and invasive breast cancers by 14–20% and nonsignificantly reduced the risk of colorectal cancer by 17%. In women taking personal calcium or vitamin D supplements, CaD did not alter cancer risk (HR: 1.06–1.26). Conclusions: For women in the WHI CaD who were not taking personal calcium or vitamin D supplements at randomization, CaD decreased the risk of total, breast, and colorectal cancers and did not change the risk of fractures or total mortality. The nonskeletal effects of CaD may be more important than the skeletal effects and should be considered when evaluating these supplements. The WHI CaD trial is registered at clinicaltrials.gov as NCT00000611.This publication has 26 references indexed in Scilit:
- Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysisBMJ, 2010
- Calcium Plus Vitamin D Supplementation and Mortality in Postmenopausal Women: The Women's Health Initiative Calcium-Vitamin D Randomized Controlled TrialThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2009
- Calcium Plus Vitamin D Supplementation and the Risk of Breast CancerJNCI Journal of the National Cancer Institute, 2008
- Vascular events in healthy older women receiving calcium supplementation: randomised controlled trialBMJ, 2008
- Statistics in Medicine — Reporting of Subgroup Analyses in Clinical TrialsThe New England Journal of Medicine, 2007
- Vitamin D Supplementation and Total MortalityA Meta-analysis of Randomized Controlled TrialsArchives of Internal Medicine, 2007
- Calcium plus Vitamin D Supplementation and the Risk of Colorectal CancerThe New England Journal of Medicine, 2006
- Calcium plus Vitamin D Supplementation and the Risk of FracturesThe New England Journal of Medicine, 2006
- Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trialBMJ, 2003
- Role of bile acids in colorectal carcinogenesisEuropean Journal of Cancer, 1995